Role of HSP90 Inhibitors in the Treatment of Cancer
Author:
Publisher
Springer International Publishing
Link
http://link.springer.com/content/pdf/10.1007/978-3-030-23158-3_6
Reference105 articles.
1. Acquaviva J, Smith DL, Jimenez J-P, Zhang C, Sequeira M, He S et al (2014) Overcoming acquired BRAF inhibitor resistance in melanoma via targeted inhibition of Hsp90 with Ganetespib. Mol Cancer Ther 13:353–363
2. Ahsan A, Ramanand SG, Whitehead C, Hiniker SM, Rehemtulla A, Pratt WB et al (2012) Wild-type EGFR is stabilized by direct interaction with HSP90 in cancer cells and tumors. Neoplasia 14:670–677
3. Akce M, Alese OB, Shaib WL, Wu CS-Y, Lesinski GB, El-Rayes BF (2018) Phase Ib trial of pembrolizumab and XL888 in patients with advanced gastrointestinal malignancies. J Clin Oncol 36:TPS526
4. Alfano L, Guida T, Provitera L, Vecchio G, Billaud M, Santoro M et al (2010) RET is a Heat Shock Protein 90 (HSP90) client protein and is knocked down upon HSP90 pharmacological block. J Clin Endocrinol 95:3552–3557
5. Banerji U, O'Donnell A, Scurr M, Pacey S, Stapleton S, Asad Y et al (2005) Phase I pharmacokinetic and pharmacodynamic study of 17-allylamino, 17-demethoxygeldanamycin in patients with advanced malignancies. J Clin Oncol 23:4152–4161
Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Heat Shock Protein 90 Inhibitor Effects on Pancreatic Cancer Cell Cultures;Pancreas;2021-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3